drugset / Trial / NCT04077853

Progesterone in Expectantly Managed Early-onset Preeclampsia

NCT04077853

Phase 4 Completed 80 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks' gestation and can present as late as 4-6 weeks postpartum

Timeline

Start
2019-12-15
Primary completion
2021-10-30
Completion
2022-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject 17-alpha-hydroxyprogesterone caproate Unknown 250 mg Intramuscular

Indications